Bone Biologics Corp [NASDAQ: BBLG] traded at a high on Wednesday, posting a 22.73 gain after which it closed the day’ session at $2.16.
The results of the trading session contributed to over 4510259 shares changing hands. Over the past one week, the price volatility of Bone Biologics Corp stands at 27.00% while the volatility over the past one month is 26.27%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for BBLG stock reached $1.14 million, with 0.53 million shares outstanding and 0.51 million shares in the current float. Compared to the average trading volume of 938.50K shares, BBLG reached a trading volume of 4510259 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bone Biologics Corp [BBLG]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BBLG shares is $19.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BBLG stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Bone Biologics Corp is set at 0.43 The Price to Book ratio for the last quarter was 0.60, with the Price to Cash per share for the same quarter was set at 6.09.
How has BBLG stock performed recently?
Bone Biologics Corp [BBLG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.50. With this latest performance, BBLG shares gained by 80.00% in over the last four-week period, additionally sinking by -44.19% over the last 6 months – not to mention a drop of -78.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BBLG stock in for the last two-week period is set at 70.23, with the RSI for the last a single of trading hit 73.64, and the three-weeks RSI is set at 66.05 for Bone Biologics Corp [BBLG]. The present Moving Average for the last 50 days of trading for this stock 1.4300, while it was recorded at 1.9400 for the last single week of trading, and 2.7600 for the last 200 days.
Bone Biologics Corp [BBLG]: Deeper insight into the fundamentals
Bone Biologics Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 23.32 and a Current Ratio set at 23.32.
Insider trade positions for Bone Biologics Corp [BBLG]
The top three institutional holders of BBLG stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in BBLG stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in BBLG stock with ownership which is approximately 5.1238%.
